|
EP2646577A2
|
|
Methods and systems for evaluating the sensitivity or resistance of tumor specimens to chemotherapeutic agents
|
|
CA2751786A1
|
|
Calibration device and methods for use with a liquid handler
|
|
WO2011103316A1
|
|
Methods for predicting a cancer patient's response to sunitinib
|
|
CA2818133A1
|
|
Biological pathways associated with chemotherapy treatment in breast cancer
|
|
EP2507396A1
|
|
Multi drug response markers for breast cancer cells
|
|
WO2011005504A1
|
|
Methods for predicting a cancer patient's response to antifolate therapy
|
|
WO2010147961A1
|
|
Methods and markers for predicting responses to chemotherapy
|
|
US2010311084A1
|
|
Methods for predicting a patient's response to egfr inhibitors
|
|
US2010331210A1
|
|
Methods and systems for evaluating the sensitivity or resistance of tumor specimens to chemotherapeutic agents
|
|
US2011238322A1
|
|
Methods of simulating chemotherapy for a patient
|
|
EP2281027A2
|
|
Methods for predicting a patient's response to egfr inhibitors
|
|
CA2700238A1
|
|
Methods for selecting active agents for cancer treatment
|
|
US2010216168A1
|
|
Methods for evaluating angiogenic potential in culture
|
|
CA2620936A1
|
|
Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
|
|
WO2004035833A1
|
|
Methods for assessing efficacy of chemotherapeutic agents
|
|
US2004023375A1
|
|
Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
|
|
AU2443502A
|
|
Method for tandem genomic/proteomic analyses of proliferating cells
|
|
US6416967B2
|
|
Method of using multicellular particulates to analyze malignant or hyperproliferative tissue
|
|
US5728541A
|
|
Method for preparing cell cultures from biologial specimens for chemotherapeutic and other assays
|
